IntegraGen Logo

IntegraGen

Provides genomic services for cancer and rare diseases, translating research to practice.

ALINT | PA

Overview

Corporate Details

ISIN(s):
FR0010908723
LEI:
969500CQD8K0BUIGDH55
Country:
France
Address:
5 RUE HENRI DESBRUERES, 91000 EVRY-COURCOURONNES

Description

IntegraGen, an OncoDNA company, specializes in translating molecular research into clinical practice, with a primary focus on cancer genomics and rare genetic diseases. The company provides comprehensive genomic services, including Next-Generation Sequencing (NGS) and advanced bioinformatics analysis, to academic researchers, biopharmaceutical companies, and clinical research organizations. Operating from a CLIA/CAP-certified laboratory, IntegraGen is a key genomics partner for oncology clinical trials. Its core mission involves identifying novel genetic biomarkers to develop and commercialize molecular diagnostic tests, delivering interpretable genomic data to advance both research and patient care.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-29 17:45
Informations privilégiées / Communiqué sur comptes, résultats
French 352.0 KB
2025-10-21 18:05
Informations privilégiées / Autres communiqués
French 254.6 KB
2025-10-06 18:30
Informations privilégiées / Autres communiqués
French 238.4 KB
2025-09-19 08:00
Informations privilégiées / Autres communiqués
French 260.2 KB
2025-07-02 07:30
Informations privilégiées / Autres communiqués
French 291.1 KB
2025-07-02 07:30
Inside Information / Other news releases
English 329.6 KB
2025-04-29 18:00
Informations privilégiées / Communiqué sur comptes, résultats
French 351.8 KB
2025-04-29 18:00
Inside Information / News release on accounts, results
English 356.4 KB
2025-01-15 18:44
Inside Information / Information on annual revenues
English 214.4 KB
2025-01-15 18:44
Informations privilégiées / Information sur chiffre d’affaires annuel
French 215.6 KB
2024-10-17 18:29
Inside Information / News release on accounts, results
English 343.2 KB
2024-10-17 18:29
Informations privilégiées / Communiqué sur comptes, résultats
French 398.7 KB
2024-07-18 18:44
Inside Information / Other news releases
English 270.7 KB
2024-07-18 18:44
Informations privilégiées / Autres communiqués
French 268.3 KB
2024-04-18 18:00
Inside Information / News release on accounts, results
English 372.7 KB

Automate Your Workflow. Get a real-time feed of all IntegraGen filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IntegraGen

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IntegraGen via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adaptive Biotechnologies Corp Logo
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America
ADPT
Adeia Inc. Logo
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
United States of America
ADEA
Aditxt, Inc. Logo
Acquires, develops, and deploys health technologies to address major health challenges.
United States of America
ADTX
Advanced Biomed Inc. Logo
Develops microfluidic biochip diagnostic systems for precision oncology.
United States of America
ADVB
AIM ImmunoTech Inc. Logo
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
United States of America
AIM
Ainos, Inc. Logo
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
United States of America
AIMD
Akero Therapeutics, Inc. Logo
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
United States of America
AKRO
Aladdin Healthcare Technologies SE Logo
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
NMI
Alaunos Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
United States of America
TCRT
Aligos Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
United States of America
ALGS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.